Skip to content
AwardedPOLGoodsPLN 18,938,340

Programy lekowe - Burosumabum i Romiplostimum

Published
Published 14 April 2026
Deadline
Closed 5 May 2026

Overview

Uniwersytecki Szpital Dziecięcy w Krakowie awarded a contract for pharmaceutical programs for Burosumab and Romiplostim, as detailed in the procurement specification. The contract was awarded to AMGEN SP. Z O.O. and Komtur Polska Sp. z o.o. for 16,359,190 PLN on 20 May 2026.

Key details

Country
POL
Status
Awarded
Category
Goods
Estimated value
PLN 18,938,340
Procedure
Open
SME suitable
Yes
Published
14 April 2026
Deadline
Closed
Classification (CPV)
Pharmaceutical products

Award outcome

Awarded value
PLN 16,359,190
Award date
20 May 2026
Contract period
— → 11 November 2027
Winners
  • AMGEN SP. Z O.O.
  • Komtur Polska Sp. z o.o.

Contract ending soon? Skim tracks incumbents and flags recompetes early. Book a demo to set up alerts.

Notice history

Every published notice in this contracting process, newest first.

  1. Contract Award Notice

    16 June 2026

  2. Contract Notice

    30 April 2026

  3. Contract Notice

    14 April 2026

Contracting authority

Get the full picture

AI analysis, bid scoring, and expert strategy for this tender

Skim analyses every tender against your company profile and tells you whether to bid, how to win, and who you are up against.

See which competitors are winning the contracts you're chasing.

15-minute call. We'll pull the win data on your real pipeline and show you what Skim does with it.

Awarded: Programy lekowe - Burosumabum i Romiplostimum — won by AMGEN SP. Z O.O. +1 — Skim